Trial Profile
Clinical Trials Insight: 700036484
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2008
Price :
$35
*
At a glance
- Drugs Naproxen etemesil (Primary)
- Indications Musculoskeletal pain; Osteoarthritis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Logical Therapeutics
- 21 Aug 2008 New trial record.